
Location: Warren, NJ (Hybrid)
Department: CEO Office / Corporate Development
Reports To: Head of Corporate Development
Pay Range: $163,000 to $204,000
Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded, and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last eight decades, we have strengthened our leadership in India’s pharmaceutical industry and fortified our promise of strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the U.S., and other economies of the emerging world. Driven by the purpose ‘Caring for Life’, Cipla’s focus has always been on making affordable, world-class medicines with a reputation for uncompromising quality standards across the world. In the last 85 + years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Cipla is a fast-growing pharmaceutical company with a continued focus on the expanse of our strong legacy. Over the last five years, Cipla has significantly expanded its portfolio and presence in the U.S. with both a generic and brand division.
Cipla North America is seeking a highly analytical and strategic leader to serve as the Lead, Strategic Analytics & Corporate Development. This role will act as a key partner to the CEO and senior leadership team, providing insights that drive strategic decision-making, business growth, and enterprise performance.
The successful candidate will combine corporate strategy, financial analysis, market intelligence, and business performance management to support growth initiatives, investment decisions, corporate development activities, and execution of strategic priorities across the North America business.
This role offers a unique opportunity to work directly with executive leadership and play a pivotal role in shaping the future direction of a growing healthcare organization.
This role offers a unique opportunity to work closely with the CEO and executive leadership team while influencing strategic decisions across an $800M+ North America business. The position provides broad exposure across commercial, operational, financial, and corporate development functions and offers meaningful impact on the organization's future growth and success.
Cipla is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, age, sex, sexual orientation, gender identity, religion, national origin, genetic information, disability, protected veteran status, or any other legally protected group status. At Cipla, we welcome people of all abilities and want to ensure that our hiring and interview process meets the needs of all applicants. If you require reasonable accommodation to make your application or interview experience a great one, please contact the recruiter.
The salary range mentioned above is an anticipated base salary range for this position. Exact salary depends on several factors such as experience, skills, education, and budget. Salary range may vary based on geographic location. In addition to base salary, this position may be eligible for benefits and participation in a bonus program based on performance and company results.

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years.
Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms.
Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients.
Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement.
An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.